MIF and systemic lupus erythematosus: Artesunate was shown to decrease MIF level in HUVEC culture with IFNα stimulation and in SLE patient-derived PBMC culture, partly through attenuating STAT1 phosphorylation, indicating a potential therapeutic effect of artesunate on SLE-associated atherosclerosis (56).